Dae-Woong Cho
Director Ejecutivo en CELLIVERY THERAPEUTICS, INC. .
Fortuna: 26 M $ al 31/03/2023
Cargos activos de Dae-Woong Cho
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CELLIVERY THERAPEUTICS, INC. | Director/Miembro de la Junta | 28/08/2014 | - |
| Director Ejecutivo | 28/08/2014 | - | |
| Director Técnico/Científico/I+D | 28/08/2014 | - | |
| Fundador | 14/03/2014 | - |
Historial de carrera de Dae-Woong Cho
Antiguos cargos conocidos de Dae-Woong Cho.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Fundador | 20/12/2005 | - |
| Presidente | 09/04/2010 | - | |
| Chonnam National University | Corporate Officer/Principal | - | - |
| YUHAN CORPORATION | Corporate Officer/Principal | - | - |
GenoCheck Co., Ltd.
 GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | - | - |
| Vanderbilt University | Corporate Officer/Principal | - | - |
Formación de Dae-Woong Cho.
| Vanderbilt University | Doctorate Degree |
| Hanyang University | Graduate Degree |
Estadísticas
Internacional
| Corea del Sur | 7 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| YUHAN CORPORATION | Health Technology |
| CELLIVERY THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
GenoCheck Co., Ltd.
GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Health Technology |
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Dae-Woong Cho
- Experiencia
